PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Trigger found for autoimmune heart attacks

Joslin Diabetes Center research may point toward new ways to diagnose and treat heart disease in people with type 1 diabetes

2011-03-24
(Press-News.org) BOSTON – March 23, 2011 – People with type 1 diabetes, whose insulin-producing cells have been destroyed by the body's own immune system, are particularly vulnerable to a form of inflammatory heart disease (myocarditis) caused by a different autoimmune reaction. Scientists at Joslin Diabetes Center have revealed the exact target of this other onslaught, taking a large step toward potential diagnostic and therapeutic tools for the heart condition.

Researchers in the lab of Myra Lipes, M.D., have shown in both mice and people that myocarditis can be triggered by a protein called alpha-myosin heavy chain, which is found only in heart muscle and in especially low quantities in human heart tissue.

While myocarditis often follows viral attacks or other infections, Dr. Lipes and her colleagues previously demonstrated that mice genetically modified to model type 1 diabetes could generate myocarditis spontaneously.

In their latest work, reported online in the Journal of Clinical Investigation, the scientists analyzed blood from such mice and identified two types of autoimmune response directed specifically against the protein, with the first response directed by a specialized kind of immune system cells called T cells and the second by antibodies.

In both mice and people, T cells are "trained" by specialized cells in the thymus, a small organ in front of the heart, to recognize the body's own cells and refrain from attacking them. The researchers found, however, that in mice these specialized training cells couldn't train on the alpha-myosin heavy chain protein because none of that protein was being produced in those cells.

Next, the scientists showed that the disease didn't develop in similar mice that were genetically engineered to produce the protein in the specialized training cells. "You can totally protect those mice from mortality, which is really extraordinary," says Dr. Lipes, an Investigator in Joslin's Section on Islet Cell & Regenerative Biology and an Assistant Professor at Harvard Medical School.

Furthermore, the studies also indicated that alpha-myosin heavy chain was not present in human thymus and that the T cells that sought out the protein could be found in the blood of healthy people. In patients with myocarditis, levels of these cells soared.

The investigation, Dr. Lipes says, suggests that people who are otherwise vulnerable to autoimmune conditions, such as those with type 1 diabetes, may be particularly vulnerable to this risk to their hearts.

Myosin heavy chain proteins are found in two very similar forms in human hearts: alpha-myosin heavy chain, which supports fast muscle contraction and may be particularly prevalent in athlete's hearts, and beta-myosin heavy chain, which is much more common and functions in slower muscle contraction. "We're trying to figure ways to identify the fragment of alpha-myosin heavy chain that is different, because that could aid in developing diagnostic tools and therapies," says Dr. Lipes.

###Joslin's HuiJuan Lv is first author on the paper. Other contributors include Evis Havari, Raju V. Gottumukkala, Lizbeth Cornivelli and Ross Smith of Joslin; Khadir Raddassi of Brigham and Women's Hospital; Takashi Matsui and Anthony Rosenzweig of Beth Israel Deaconess Medical Center; Roderick T. Bronson of Harvard Medical School; Anne L. Fletcher, Shannon J. Turley and Kai Wucherpfennig of Dana Farber Cancer Institute; Sheena Pinto and Bruno Kyewski of the German Cancer Research Center.

Lead funders were the National Institutes of Health and the Juvenile Diabetes Research Foundation.

About Joslin Diabetes Center

Joslin Diabetes Center is the world's preeminent diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Founded in 1898 by Elliott P. Joslin, M.D., Joslin is an independent, nonprofit institution affiliated with Harvard Medical School. For more information about Joslin, visit www.joslin.org.


ELSE PRESS RELEASES FROM THIS DATE:

Investigations show that telomerase inhibitor PinX1 is a key tumor suppressor

2011-03-24
BOSTON – It's been nearly 10 years since Beth Israel Deaconess Medical Center (BIDMC) scientists Kun Ping Lu, MD, PhD and Xiao Zhen Zhou, MD, discovered PinX1, the first potent endogenous protein shown to inhibit telomerase in mammals. Now the scientific team has discovered a vitally important new function for this telomerase inhibitor. The investigators report in today's on-line edition of the Journal of Clinical Investigation (JCI) that low levels of PinX1 contribute to cancer development, providing the first genetic evidence linking telomerase activation to chromosome ...

Researchers sequence multiple myeloma genome in landmark Nature study

2011-03-24
HACKENSACK, N.J. (March 23, 2011) — Using new genome sequencing technologies, researchers from the John Theurer Cancer Center at Hackensack University Medical Center joined colleagues from 20 major North American research institutions to publish the first complete genomic portrait of multiple myeloma, a highly aggressive blood cancer. Findings from the study point to new directions for potential myeloma therapies, and begin to unlock the mysteries of what causes this devastating malignancy. The paper will be published in the March 24, 2011 issue of Nature. Multiple ...

Arthritis drug could help beat melanoma skin cancer

2011-03-24
A breakthrough discovery by the University of East Anglia (UEA) and Children's Hospital Boston promises an effective new treatment for one of the deadliest forms of cancer. Reporting in the March 24 edition (front cover story) of the journal Nature, the researchers found that leflunomide - a drug commonly used to treat rheumatoid arthritis – also inhibits the growth of malignant melanoma. Melanoma is a cancer of the pigment cells in our skin. It is the most aggressive form of skin cancer and, unlike most other cancers, incidence of the disease is increasing. More than ...

A very cool pair of brown dwarfs

A very cool pair of brown dwarfs
2011-03-24
Brown dwarfs are essentially failed stars: they lack enough mass for gravity to trigger the nuclear reactions that make stars shine. The newly discovered brown dwarf, identified as CFBDSIR 1458+10B, is the dimmer member of a binary brown dwarf system located just 75 light-years from Earth [1]. The powerful X-shooter spectrograph on ESO's Very Large Telescope (VLT) was used to show that the composite object was very cool by brown dwarf standards. "We were very excited to see that this object had such a low temperature, but we couldn't have guessed that it would turn out ...

Lung cancer study finds mentholated cigarettes no more harmful than regular cigarettes

2011-03-24
Smokers of mentholated cigarettes are no more likely to develop lung cancer than other smokers, according to a new, very large, prospective study of black and white smokers published online March 23 in the Journal of the National Cancer Institute. In fact, contrary to a popular hypothesis, menthol smokers in this study had a somewhat lower risk of developing and dying from lung cancer than non-menthol smokers. Lung cancer rates are higher among blacks than whites, and use of mentholated cigarettes, also higher among blacks, has been suggested as a possible explanation. ...

2 new targets for melanoma therapies

2011-03-24
The latest clues suggesting potential new ways to treat melanoma come from an unlikely source: fish. Zebrafish don't get sunburns, but they can get skin cancer – at least those fish that have been engineered to model the often deadly human cancer. When Leonard Zon, a Howard Hughes Medical Institute investigator at Children's Hospital Boston, developed this melanoma model five years ago, he hoped to use the tiny striped fish to discover new melanoma genes or new therapies for this aggressive cancer that consistently eludes treatment. Now, in work described in two papers ...

First look at the full multiple myeloma genome reveals new insights, discoveries

2011-03-24
Scientists have unveiled the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, a form of blood cancer. A study of the genomes from 38 cancer samples has yielded new and unexpected insights into the events that lead to this form of cancer and could influence the direction of multiple myeloma research. This work, led by scientists at the Broad Institute and Dana-Farber Cancer Institute, appears in the March 24 issue of Nature. Multiple myeloma is the second most common blood cancer in the United States and causes about 20,000 new cases ...

Drug prevents Type 2 diabetes in majority of high-risk individuals

2011-03-24
SAN ANTONIO, Texas, U.S.A. (March 24, 2011) — A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease, U.S. scientists reported today. The team also noted a 31 percent decrease in the rate of thickening of the carotid artery, the major vessel that supplies blood to the brain. The study, which enrolled 602 participants through The University of Texas Health Science Center San Antonio and seven collaborating centers, is described in the New ...

Mouse cancer genome unveils genetic errors in human cancers

2011-03-24
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse. By sequencing the genome of a mouse with cancer, researchers at Washington University School of Medicine in St. Louis have uncovered mutations that also drive cancer in humans. The investigators are the first to sequence a mouse cancer genome, and their research is reported online March 23 in the Journal of Clinical Investigation. "This approach gives us a way to rapidly evaluate ...

New insight into how environmental enrichment enhances memory

2011-03-24
It is well established that environmental enrichment, providing animals with rich sensory, motor, and social stimulation, produces both dramatic increases in the number of synapses in the brain and enhanced learning. However, causal relationships between synapse formation and improved memory have not been definitively established. Now, a new study published by Cell Press in the March 24 issue of the journal Neuron introduces a valuable model system for investigating the role of synapse turnover in learning and memory in adult animals and elucidates mechanisms that link ...

LAST 30 PRESS RELEASES:

Study: ChatGPT displays lower concern for child development “warning signs” than physicians

Study: Childcare is unaffordable for U.S. medical residents

Study: New approach to equitable social care connects pediatric caregivers to resources without screening

Study: Rural children struggle to access hospital services

Study: Longer use of breathing device supports lung growth in preterm infants

Study: Newborn umbilical cord procedure safe for long-term neurodevelopment in children

Study: Eye ultrasounds may assist with detecting brain shunt failure in children

Study: Children with hypertension at higher long-term risk for serious heart conditions

Study: Rotavirus vaccinations in NICU pose minimal risk

Study: Long COVID symptoms in children vary by age

Study: Multicomponent intravenous lipid emulsion improves brain development in preterm infants

PAS 2024: Nemours Children’s Health researchers to present on youth mental health, vaccination, autism and respiratory illness

Lake tsunamis pose significant threat under warming climate

New Nevada experiments will improve monitoring of nuclear explosions

New study challenges one-size-fits-all approach to vitamin D supplementation guidelines

MBL Director Nipam Patel elected to National Academy of Sciences

The future of digital agriculture

Lahar detection system upgraded for mount rainier

NCSA's Bill Gropp elected to AAAS Council

George Mason University receives over $1.1 million to revolutionize Lyme disease testing

NASA selects BAE systems to develop air quality instrument for NOAA

For microscopic organisms, ocean currents act as 'expressway' to deeper depths, study finds

Rice’s Harvey, Ramesh named to National Academy of Sciences

Oil palm plantations are driving massive downstream impact to watershed

Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl

New eco-friendly lubricant additives protect turbine equipment, waterways

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy appoints new Deputy Editor-in-Chief, Andrei Moroz, PhD

Optical pumped magnetometer magnetocardiography as a potential method of therapy monitoring in fulminant myocarditis

Heart failure registries in Asia – what have we learned?

Study helps understand how energy metabolism is regulated at cellular level

[Press-News.org] Trigger found for autoimmune heart attacks
Joslin Diabetes Center research may point toward new ways to diagnose and treat heart disease in people with type 1 diabetes